Updated Jul 16, 2026
SIEGAL JONATHAN has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $335K.
Jonathan Siegal serves as the Principal Accounting Officer at Vericel Corp, a biopharmaceutical company focused on therapies for sports medicine and severe burn care. His role primarily involves overseeing the company's accounting functions.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | VCEL | Vericel Corp | S — Open-market sale | 2.5K | $44.90 | $112K |
| 2026-06-30 | VCEL | Vericel Corp | M — Option exercise | 2.5K | $29.82 | $75K |
| 2026-06-30 | VCEL | Vericel Corp | S — Open-market sale | 232 | $44.90 | $10K |
| 2026-05-08 | VCEL | Vericel Corp | S — Open-market sale | 1.4K | $40.50 | $58K |
| 2026-05-08 | VCEL | Vericel Corp | S — Open-market sale | 3.4K | $38.00 | $130K |
| 2026-02-26 | VCEL | Vericel Corp | F — Tax withholding / forfeiture | 738 | $38.25 | $28K |
| 2026-02-26 | VCEL | Vericel Corp | M — Option exercise | 1.9K | $0.00 | |
| 2026-02-26 | VCEL | Vericel Corp | F — Tax withholding / forfeiture | 627 | $38.09 | $24K |
| 2026-02-26 | VCEL | Vericel Corp | M — Option exercise | 1.5K | $0.00 | |
| 2026-02-20 | VCEL | Vericel Corp | F — Tax withholding / forfeiture | 188 | $37.41 | $7K |
| 2026-02-20 | VCEL | Vericel Corp | M — Option exercise | 420 | $0.00 | |
| 2026-02-20 | VCEL | Vericel Corp | F — Tax withholding / forfeiture | 1.1K | $36.82 | $41K |
| 2026-02-20 | VCEL | Vericel Corp | M — Option exercise | 2.5K | $0.00 | |
| 2025-09-30 | VCEL | Vericel Corp | F — Tax withholding / forfeiture | 370 | $31.47 | $12K |
| 2025-09-30 | VCEL | Vericel Corp | M — Option exercise | 938 | $0.00 | |
| 2024-10-02 | VCEL | Vericel Corp | S — Open-market sale [10b5-1] | 568 | $41.90 | $24K |
| 2024-10-02 | VCEL | Vericel Corp | F — Tax withholding / forfeiture [10b5-1] | 369 | $42.25 | $16K |
| 2024-10-02 | VCEL | Vericel Corp | M — Option exercise [10b5-1] | 937 | $0.00 |
Jonathan Siegal serves as the Principal Accounting Officer at Vericel Corp, a biopharmaceutical company focused on therapies for sports medicine and severe burn care. His role primarily involves overseeing the company's accounting functions.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 5 open-market sales ($335K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live SIEGAL JONATHAN profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.